SynopsisThe global market for Healthcare Nanotechnology was valued at US$ 246930 million in the year 2024 and is projected to reach a revised size of US$ 464970 million by 2031, growing at a CAGR of 9.6% during the forecast period. It is defined as the study of .....
SynopsisThe global market for Hybrid Operating Rooms was valued at US$ 4970 million in the year 2024 and is projected to reach a revised size of US$ 7240 million by 2031, growing at a CAGR of 5.6% during the forecast period. A hybrid operating room is an OR equi.....
SynopsisThe global market for Chain Pharmacy Prescription Drugs was valued at US$ 35000 million in the year 2024 and is projected to reach a revised size of US$ 40370 million by 2031, growing at a CAGR of 2.1% during the forecast period. Prescription drugs play .....
SynopsisThe global market for Nausea And Vomiting Treatment was valued at US$ 5887 million in the year 2024 and is projected to reach a revised size of US$ 9093 million by 2031, growing at a CAGR of 6.5% during the forecast period. Nausea and Vomiting Treatment .....
SynopsisThe global market for Cancer Respiratory Biopsy was valued at US$ 350 million in the year 2024 and is projected to reach a revised size of US$ 1251 million by 2031, growing at a CAGR of 20.0% during the forecast period. Cancer respiratory biopsy is a non.....
SynopsisThe global market for Stent Grafts was valued at US$ 4495 million in the year 2024 and is projected to reach a revised size of US$ 7647 million by 2031, growing at a CAGR of 8.0% during the forecast period. A stent graft or covered stent is type of vascu.....
SynopsisThe global market for Traveler's Diarrhea Therapeutics was valued at US$ 900 million in the year 2024 and is projected to reach a revised size of US$ 1445 million by 2031, growing at a CAGR of 7.1% during the forecast period. Traveler"s diarrhea (TD) is .....
SynopsisThe global market for Transcriptomics was valued at US$ 4561 million in the year 2024 and is projected to reach a revised size of US$ 8808 million by 2031, growing at a CAGR of 10.0% during the forecast period. Transcriptomic incorporates the exploration.....
SynopsisThe global market for Recombinant Human Glial Cell Maturation Factor β was valued at US$ 104 million in the year 2024 and is projected to reach a revised size of US$ 159 million by 2031, growing at a CAGR of 6.5% during the forecast period. GMF-beta belo.....
SynopsisThe global market for Hemostasis Valves was valued at US$ 164 million in the year 2024 and is projected to reach a revised size of US$ 264 million by 2031, growing at a CAGR of 7.2% during the forecast period. A hemostasis valve including a collapsible m.....
